Skip to main content

Research News

Crack GPAT — Prepare for GPAT Online 
  • Ultrasound has potential to damage coronaviruses : Study finds

    The coronavirus’ structure is an all-too-familiar image, with its densely packed surface receptors resembling a thorny crown. These spike-like proteins latch onto healthy cells and trigger the invasion of viral RNA. While the virus’ geometry and infection strategy is generally understood, little is known about its physical integrity.

  • New class of substances for redox reactions

    Redox reactions play an important role in our everyday life. In these reactions, one compound releases electrons and is oxidized, while another accepts electrons and is reduced. Such redox reactions are exploited by living organisms, for example, to store energy.

  • Enzymatic danse macabre of lung cancer

    A chromatin-regulating enzyme has been shown by in-depth interdisciplinary investigations to be a key driver of a common type of lung cancer. Drugs that target the enzyme could improve treatment and survival rates for this particular cancer.

  • Amalaki Rasayana is effective in cardiac hypertrophy, says Research

    Using the integrated approach of cheminformatics and network systems biology, Researchers from IIT Guwahati investigated Amalaki Rasayana (AR), an Ayurvedic rejuvenate for the treatment of cardiovascular diseases such as pressure-overload left ventricular cardiac hypertrophy (LVCH). The study has been published in the Nature Partnership Journal System Biology and Applications.

  • Study warns Diphtheria could become a major global threat

    In a new health scare, a team of researchers from India, the UK and Russia, has found that Diphtheria, which is a relatively easily-preventable infection, has started to become resistant to several classes of antibiotics, and in future, it may even become immune to vaccination. In a report, the team has also suggested that there was a possibility of the disease once more becoming a major threat across the globe because of the impact of COVID-19 on vaccination schedules in different parts of the world, coupled with a rise in the number of infections.

  • Atherosclerosis can accelerate the development of clonal hematopoiesis : Study

    Billions of peripheral white blood cells are produced every day by the regular divisions of hematopoietic stem cells and their descendants in the bone marrow. Under normal circumstances, thousands of stem cells contribute progeny to the blood at any given time, making white blood cells a group with diverse ancestry.

  • ‘Crowd and Mask’ Monitoring System to prevent COVID-19

    Innovators at Indian Institute of Science Education and Research (IISER), Bhopal have developed a unique ‘Crowd and Mask’ Monitoring System to prevent COVID-19 from spread. This one-of-its-kind low cost Artificial Intelligence (AI)-enabled device is portable and easy to deploy across various locations, says a statement released by the institution.

  • Novel technique may help in early detection of Cancer, Alzheimer’s, and Parkinson’s

    Scientists from Raman Research Institute (RRI) have developed a new technique to measure DNA modifications that can have applications in the early diagnosis of multiple diseases like Cancer, Alzheimer’s, and Parkinson’s diseases.

  • Neurologists Identify Consistent Neuroinflammatory Response in ICH Patients

    Understanding how the immune system responds to acute brain hemorrhage could open doors to identifying treatments for this devastating disease. However, up until now, there has been limited information on inflammation in the brain from human patients, especially during the first days after a hemorrhagic stroke.

    This led a team of researchers to partner with a large clinical trial of minimally-invasive surgery to tackle defining the human neuroinflammatory response in living patients.

  • New potential drug to treat SARS-CoV-2

    A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by a research team from Texas A&M University and The University of Texas Medical Branch (UTMB).

    The medication bepridil, which goes by the trade name Vascor, is currently approved by the U.S. Food and Drug Administration (FDA) to treat angina, a heart condition.

Subscribe to Research News